Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Therapy Effect on Androgen Status and Erectile Function in Men With High Cardiovascular Risk
NCT07460960Phase 2Recruiting
- Sponsor
- Lomonosov Moscow State University Medical Research and Educational Center
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of pitavastatin and rosuvastatin in cardiovascular disease (CVD) and erectile dysfunction (ED) (2 arms), sponsored by Lomonosov Moscow State University Medical Research and Educational Center. Primary endpoints: Objective assessment of erectile function parameters at 6 months and Androgen status at 6 months. Started Mar 2026; status: recruiting.
02
Drugs
pitavastatinrosuvastatin
03
Conditions
cardiovascular disease (CVD)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07460960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07460960.